MTOR and non-small cell lung carcinoma: The PI3K-Akt-mTOR pathway is commonly deregulated in several human malignancies including NSCLC [96], and activated PI3K signal increased accumulation of Nrf2 into the nucleus to enhance the transcription of enzymes involved in the pentose phosphate pathway [72].